<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="Activity\PMC7848973\results\search\disease\results.xml">
  <result pre="subcordata Oliv. medicinal plant traditionally used for the treatment of" exact="malaria" post="in Nigeria are studied alongside two semisynthetic analogues (compounds"/>
  <result pre="subcordata Oliv. medicinal plant traditionally used for the treatment of" exact="malaria" post="in Nigeria are studied alongside two semisynthetic analogues (compounds"/>
  <result pre="cycleanine is then investigated in suppressive, prophylactic, and curative murine" exact="malaria" post="models after infection with a chloroquine-sensitive Plasmodium berghei strain."/>
  <result pre="cycleanine and its analogues as leads for further development. KEYWORDS" exact="malaria" post="Plasmodium falciparum Plasmodium berghei bisbenzylisoquinoline alkaloids cycleanine metabolism in"/>
  <result pre="etiological agent Plasmodium falciparum, exerts an immense economic impact. While" exact="malaria" post="cases and mortality figures continue to fall (1, 2),"/>
  <result pre="resistance to available chemotherapeutic agents poses a significant threat to" exact="malaria" post="treatment and management (3). Natural products of plant origin"/>
  <result pre="semisynthetic derivatives, has become the first-line therapy for P. falciparum" exact="malaria" post="(6, 7). However, due to the development of artemisinin"/>
  <result pre="used for the treatment of a range of diseases, including" exact="malaria" post="(11, 12). The bioactive components of T. subcordata are"/>
  <result pre="used to establish in vivo antimalarial activity in a murine" exact="malaria" post="model. In addition, the metabolites and metabolic pathways of"/>
  <result pre="stages of the P. falciparum Dd2 chloroquine-resistant strain using a" exact="malaria" post="SYBR green I fluorescence assay. These data are provided"/>
  <result pre="no.) IC50 (Î¼M) against P. falciparum straina,d: CC50 (Î¼M) against" exact="cancer" post="cell line(s): SIf Dd2 W2 D6 KBb or HCTc"/>
  <result pre="investigate its toxicity in healthy mice and efficacy in murine" exact="malaria" post="models after infection with Plasmodium berghei. The acute median"/>
  <result pre="weight/day) following P. berghei infection was demonstrated through a significant" exact="suppression" post="of parasitemia and an increased mean survival time (MST)"/>
  <result pre="the higher dose (50â€‰mg/kg/day) showed efficacy, both in terms of" exact="suppression" post="of parasitemia and in MST, comparable to that for"/>
  <result pre="(Table 3). At the higher dose (50â€‰mg/kg), cycleanine showed a" exact="suppression" post="of parasitemia by 59.0%, only slightly less than that"/>
  <result pre="methodologies (16) used to determine IC50 or the different mammalian" exact="cancer" post="cells or P. falciparum clones used. The semisynthetic analogues"/>
  <result pre="the mechanism of action (e.g., cellular uptake) of cycleanine in" exact="cancer" post="cells using click chemistry (15), and can also be"/>
  <result pre="its safety in healthy mice and efficacy in a murine" exact="malaria" post="model was investigated. The LD50 (4.5 g/kg) of cycleanine"/>
  <result pre="previously in mice (24). Using suppression, prophylactic, and curative murine" exact="malaria" post="models after infection with P. berghei (25), cycleanine showed"/>
  <result pre="with a wide safety margin, are required to help alleviate" exact="malaria" post="morbidity and mortality and to contribute to the global"/>
  <result pre="and mortality and to contribute to the global control of" exact="malaria" post="and infectious diseases. MATERIALS AND METHODS Chemicals. Chloroquine and"/>
  <result pre="in stained films (Giemsa stain) under a microscope. The average" exact="suppression" post="of parasitemia (%) was calculated as follows: average %"/>
  <result pre="declare no conflict of interest. References REFERENCES 1.collab: WHO. 2019World" exact="malaria" post="report 2019. World Health Organization, Geneva, Switzerlandhttps://apps.who.int/iris/rest/bitstreams/1262394/retrieve. 2.BhattS, WeissDJ,"/>
  <result pre="LynchM, LindgrenF, CohenJM, MurrayCLJ, SmithDL, HaySI, CibulskisRE, GethingPW2015The effect of" exact="malaria" post="control on Plasmodium falciparum in Africa between 2000 and"/>
  <result pre="PasajeCFA, HerrmannS, YangT, GillettDL, DickLR, RalphSA, DogovskiC, SpillmanNJ, TilleyL2018Artemisinin kills" exact="malaria" post="parasites by damaging proteins and inhibiting the proteasome. Nat"/>
  <result pre="additional alkaloids from Triclisia subcordata, induced cytotoxicity and apoptosis in" exact="ovarian cancer" post="cell lines. RSC Adv7:44154â€&quot;44161. doi:10.1039/C7RA08032H. 15.UcheFI, McCullaghJ, ClaridgeTWD, RichardsonA,"/>
  <result pre="alkaloids from Triclisia subcordata, induced cytotoxicity and apoptosis in ovarian" exact="cancer" post="cell lines. RSC Adv7:44154â€&quot;44161. doi:10.1039/C7RA08032H. 15.UcheFI, McCullaghJ, ClaridgeTWD, RichardsonA,"/>
  <result pre="of (aminoalkyl)cycleanine analogues: cytotoxicity, cellular uptake, and apoptosis induction in" exact="ovarian cancer" post="cells. Bioorg Med Chem Lett28:1652â€&quot;1656. doi:10.1016/j.bmcl.2018.03.038.29588214 16.AngerhoferCK, GuinaudeauH, WongpanichV,"/>
  <result pre="(aminoalkyl)cycleanine analogues: cytotoxicity, cellular uptake, and apoptosis induction in ovarian" exact="cancer" post="cells. Bioorg Med Chem Lett28:1652â€&quot;1656. doi:10.1016/j.bmcl.2018.03.038.29588214 16.AngerhoferCK, GuinaudeauH, WongpanichV,"/>
  <result pre="HorrocksP, LiWW2018The synthesis and evaluation of thymoquinone analogues as anti-ovarian" exact="cancer" post="and antimalarial agents. Bioorg Med Chem Lett28:1219â€&quot;1222. doi:10.1016/j.bmcl.2018.02.051.29519737 23.DrewesG,"/>
 </snippets>
</snippetsTree>
